Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
BB1608
Top 10 late-stage cancer drugs in 2012
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Amgen
Ariad Pharmaceuticals
Astellas
Aveo
Bayer
BB1608
Boston Biomedical
cabozantinib
Carfilzomib
Dainippon Sumitomo
Enzalutamide
Exelixis
Genentech
Immunogen
Medivation
Oncovex
ONYX Pharmaceuticals
Ponatinib
Regeneron
regorafenib
Roche
Sanofi
T-DM1
tivozanib
Zaltrap
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT